ConductScience.org, home

Paper36959692

Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center

Cengiz Seval G and 10 others. Balkan Med J, 2023. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center. Papers, record 36959692. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36959692

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center
PubMed
Journal
Balkan Med J
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.14
iCite
Revised in PubMed
2023-05-16
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Primary MyelofibrosisMajor topic
Hematopoietic Stem Cell TransplantationMajor topic
Graft vs Host DiseaseMajor topic
Humans
Treatment Outcome
Retrospective Studies
Cross-Sectional Studies

Source PubMed

Download CSV of topics

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119879949Outcome of transplantation for myelofibrosis.Biol Blood Marrow Transplant2010https://conductscience.org/library/papers/19879949PubMed
223838352Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report.Blood2013https://conductscience.org/library/papers/23838352PubMed
329808926Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT.Br J Haematol2018https://conductscience.org/library/papers/29808926PubMed
432286544Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation.Leukemia2021https://conductscience.org/library/papers/32286544PubMed
533108024Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study.Am J Hematol2021https://conductscience.org/library/papers/33108024PubMed
620008785A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment).Blood2010https://conductscience.org/library/papers/20008785PubMed
722909192Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting.Br J Haematol2012https://conductscience.org/library/papers/22909192PubMed
832165328Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy.Biol Blood Marrow Transplant2020https://conductscience.org/library/papers/32165328PubMed
910733489Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.Blood2000https://conductscience.org/library/papers/10733489PubMed
104153799Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.Transplantation1974https://conductscience.org/library/papers/4153799PubMed
1132384540Survival following allogeneic transplant in patients with myelofibrosis.Blood Adv2020https://conductscience.org/library/papers/32384540PubMed
1225529383National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.Biol Blood Marrow Transplant2015https://conductscience.org/library/papers/25529383PubMed
1331284069
Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant2019https://conductscience.org/library/papers/31284069PubMed
1434052505Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis-A Systematic Review and Meta-Analysis.Transplant Cell Ther2021https://conductscience.org/library/papers/34052505PubMed
1530408564Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation.Biol Blood Marrow Transplant2019https://conductscience.org/library/papers/30408564PubMed
1624862637CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation.Biol Blood Marrow Transplant2014https://conductscience.org/library/papers/24862637PubMed
1721133885Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).Br J Haematol2011https://conductscience.org/library/papers/21133885PubMed
1823573823Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation.Leuk Lymphoma2014https://conductscience.org/library/papers/23573823PubMed
1930872371State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019.Haematologica2019https://conductscience.org/library/papers/30872371PubMed
2032297800Management of myelofibrosis after ruxolitinib failure.Leuk Lymphoma2020https://conductscience.org/library/papers/32297800PubMed

See all 38 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41815185Clinical Outcomes of Allogeneic Stem Cell Transplantation in Myelofibrosis - A Single Center Experience.Blood Cell Ther2026https://conductscience.org/library/papers/41815185

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
JAK23717PubTator's text mininghttps://conductscience.org/library/genes/3717NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36959692

GET https://conductscience.org/api/papers/v1/36959692/references?page=2